Language selection

Search

Details for: BORTEZOMIB FOR INJECTION - 3.5 mg

Company: TEVA CANADA LIMITED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02423405BORTEZOMIB FOR INJECTIONBORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER)3.5 MG / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02423405BORTEZOMIB FOR INJECTIONBORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER)3.5 MG / VIALPOWDER FOR SOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Bortezomib (VELCADE and generics) - Assessing the Potential Risk of Flesh-Eating Disease (Necrotizing Fasciitis)
Summary Safety Review - Bortezomib (VELCADE and Generics) - Assessing a Potential Link with Flesh-Eating Disease (Necrotising Fasciitis)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: